City of Hope

City of Hope is a pioneering organization with a mission to provide advanced cures and treatments for a range of life-threatening illnesses. Having been established in 1913, it has evolved into a prominent entity within the U.S., specializing in cancer research and treatment as well as being a leading research center for diabetes. The comprehensive cancer center designated by the National Cancer Institute forms the foundation of City of Hope, offering an integrated model covering cancer care, research, development, academic training, and innovation initiatives. Notably, City of Hope has contributed significantly to breakthrough cancer medicines and biomedical advancements such as human synthetic insulin and monoclonal antibodies. The organization's footprint extends across the United States, including its Los Angeles campus, a network of clinical care locations in Southern California, a new cancer center in Orange County, and treatment facilities in Atlanta, Chicago, and Phoenix. City of Hope's affiliated entities encompass the Translational Genomics Research Institute and AccessHope™. With its commitment to revolutionizing healthcare, City of Hope sets a transformative precedent within the Education and Health Care industries.